Eosinophil Granule Proteins and Their Functions
嗜酸性粒细胞颗粒蛋白及其功能
基本信息
- 批准号:6703673
- 负责人:
- 金额:$ 38.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-05-01 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Considerable evidence indicates that the eosinophil is important in resistance to parasites and in hypersensitivity diseases, such as bronchial asthma. The eosinophil is equipped with weapons to damage helminths and host tissues, including cationic proteins, reactive oxygen species, leukotrienes, and the ability to elaborate cytokines. In human diseases, eosinophils accumulate in massive numbers and discharge their granule proteins onto affected tissues, often in association with damage or frank necrosis. Under the auspices of this grant, we have investigated the structure and function of eosinophil granule proteins, including major basic protein (MBP1), eosinophil-derived neurotoxin (EDN), eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO). These proteins are toxins and damage cells and tissues; MBP1 and EPO are able to stimulate cells. Further, MBP1 causes bronchial hyperreactivity in monkeys and guinea pigs. We have discovered a novel granule protein, the MBP homologue (MBP2). Like MBP1, MBP2 damages and activates target cells. However, whether MBP2 possesses distinctive properties not shared by MBP1 is unknown. MBP1 is synthesized as a 32 kDa promolecule (proMBP1) and is processed to its 14 kDa mature form; but little is known of the proMBP convertase. Also, the crystal structure of proMBP1 is unknown. Preliminary analyses of the eosinophil granule proteome indicate the presence of numerous novel peptides. Here we identify a series of interrelated goals to investigate these issues. First, we will compare the properties of MBP1 and MBP2 and determine whether unique properties exist for MBP2. Second, we will characterize the enzyme(s) converting 32 kDa proMBP to 14 kDa MBP (proMBP convertase). Third, in collaboration, we will crystallize recombinant proMBP and solve its structure. Fourth, we will characterize the novel acidic eosinophil granule proteins discovered using two-dimensional electrophoresis and mass spectroscopy. Finally, we will determine whether two novel markers of eosinophil activation are detectable in patients with eosinophilia. Overall, these studies will expand our knowledge of the molecules composing the eosinophil granule and provide new tools to dissect eosinophil function in disease.
描述(由申请人提供):大量证据表明嗜酸性粒细胞在抵抗寄生虫和过敏性疾病(如支气管哮喘)中很重要。嗜酸性粒细胞配备了武器来破坏蠕虫和宿主组织,包括阳离子蛋白、活性氧、白三烯,以及制造细胞因子的能力。在人类疾病中,嗜酸性粒细胞大量积聚并将其颗粒蛋白排放到受影响的组织中,通常与损伤或直接坏死有关。在这项资助下,我们研究了嗜酸性粒细胞颗粒蛋白的结构和功能,包括主要碱性蛋白(MBP1)、嗜酸性粒细胞衍生神经毒素(EDN)、嗜酸性粒细胞阳离子蛋白(ECP)和嗜酸性粒细胞过氧化物酶(EPO)。这些蛋白质是毒素,会损害细胞和组织;MBP1和EPO能够刺激细胞。此外,MBP1会导致猴子和豚鼠的支气管高反应性。我们发现了一种新的颗粒蛋白,即MBP同源物(MBP2)。和MBP1一样,MBP2也会损伤和激活靶细胞。然而,MBP2是否具有MBP1所不具有的独特特性尚不清楚。MBP1作为32 kDa的前分子(proMBP1)合成,并被加工成14 kDa的成熟形式;但人们对proMBP转化酶知之甚少。此外,proMBP1的晶体结构也是未知的。对嗜酸性粒细胞颗粒蛋白质组的初步分析表明存在许多新的肽。在这里,我们确定了一系列相互关联的目标来研究这些问题。首先,我们将比较MBP1和MBP2的属性,确定MBP2是否存在独特的属性。其次,我们将描述将32 kDa的proMBP转化为14 kDa的MBP的酶(proMBP转化酶)。第三,通过合作,我们将对重组proMBP进行结晶并解决其结构问题。第四,我们将利用二维电泳和质谱技术对发现的新型酸性嗜酸性粒细胞颗粒蛋白进行表征。最后,我们将确定在嗜酸性粒细胞增多症患者中是否可以检测到两个新的嗜酸性粒细胞激活标记。总之,这些研究将扩大我们对组成嗜酸性粒细胞颗粒的分子的认识,并为剖析嗜酸性粒细胞在疾病中的功能提供新的工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gerald J Gleich其他文献
Lidocaine may inhibit interleukin-5-induced signal transduction by blocking protein kinase C activity
- DOI:
10.1016/s0091-6749(02)82134-0 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Jennifer L Bankers-Fulbright;Gail M Kephart;Matthew P Abdel;Patricia L Caffes;Kara Hurlihy;Gerald J Gleich - 通讯作者:
Gerald J Gleich
VENOM IMMUNOTHERAPY FOR HONEYBEE STING-SENSITIVE PERSONS
针对对蜜蜂蜇刺敏感人群的毒液免疫疗法
- DOI:
10.1203/00006450-197704000-00761 - 发表时间:
1977-04-01 - 期刊:
- 影响因子:3.100
- 作者:
John W Yunginger;Barry R Paull;Gerald J Gleich;G S Gilchrist - 通讯作者:
G S Gilchrist
Gerald J Gleich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gerald J Gleich', 18)}}的其他基金
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
利用针对嗜酸性粒细胞颗粒主要碱性蛋白的中和剂开发治疗嗜酸性粒细胞介导的过敏性炎症疾病的方法
- 批准号:
10401936 - 财政年份:2021
- 资助金额:
$ 38.62万 - 项目类别:
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
利用针对嗜酸性粒细胞颗粒主要碱性蛋白的中和剂开发治疗嗜酸性粒细胞介导的过敏性炎症疾病的方法
- 批准号:
10257909 - 财政年份:2021
- 资助金额:
$ 38.62万 - 项目类别:
Novel, Non-InvasiveImaging of Eosinophil-Related Inflammation Throughout the Esophagus in Patients withEosinophilic Esophagitis
嗜酸性粒细胞性食管炎患者食管内嗜酸性粒细胞相关炎症的新型非侵入性成像
- 批准号:
10017684 - 财政年份:2020
- 资助金额:
$ 38.62万 - 项目类别:
STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON
用于数据比较的嗜酸性粒细胞相关参数的标准值
- 批准号:
7718523 - 财政年份:2008
- 资助金额:
$ 38.62万 - 项目类别:
CLINICAL TRIAL: ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
临床试验:艾替班特治疗遗传性血管性水肿
- 批准号:
7718517 - 财政年份:2008
- 资助金额:
$ 38.62万 - 项目类别:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
高嗜酸性粒细胞综合征和美泊利珠单抗
- 批准号:
7718504 - 财政年份:2008
- 资助金额:
$ 38.62万 - 项目类别:
ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
Icatibant 用于治疗遗传性血管性水肿
- 批准号:
7604975 - 财政年份:2007
- 资助金额:
$ 38.62万 - 项目类别:
STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON
用于数据比较的嗜酸性粒细胞相关参数的标准值
- 批准号:
7604980 - 财政年份:2007
- 资助金额:
$ 38.62万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 38.62万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别: